Expression of intercellular adhesion molecule-3 (ICAM-3/CD50) in malignant lymphoproliferative disorders and solid tumors

Tissue Antigens

Volumn 48, Issue 4 I, 1996, Pages 271-277

  Terol, M J ^a   Cid, M C ^a   Lopez Guillermo A ^a   Juan, M ^a,c   Yague J ^a   Miralles, A ^a   Vilella, R ^a   Vives, J ^a   Cardesa, A ^a   Montserrat, E ^a   Campo, E ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

CD50; Endothelial cell; Hodgkin's disease; ICAM 3; Non Hodgkin's lymphoma; Solid tumor

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 3; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); NONHODGKIN LYMPHOMA; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; SOLID TUMOR;

PHRAGMITES;

EID: 10344235274     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02645.x     Document Type: Article

References (36)

1. Springer TA. Adhesion receptors of the immune system. Nature 1990: 346: 425-434.
2. Hynes RO. Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992: 69: 11-25.
3. Albelda SM. Role of integrins and ither cell adhesion molecules in tumor progression and metastases. Lab Invest 1993: 68: 4-17.
4. de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991: 174: 253-267.
5. de Fougerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 1992: 175: 185-190.
6. de Fougerolles AR, Qin X, Springer TA. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med 1994: 179: 619-629.
7. Fawcett J, Holness CLL, Needham LA et al. Molecular cloning of ICAM-3, a third ligand for LFA-1, constituvely expressed on resting leukocytes. Nature 1992: 360: 481-484.
8. Vazeux R, Hoffman PA, Tomita JK et al. Cloning and characterization of a new intercellular adhesion molecule ICAM-R. Nature 1992: 360: 485-488.
9. de Fougerolles AR, Klickstein LB, Springer TA. Cloning and expression of intercellular adhesion molecule 3 reveals strong homology to other immunoglobulin family counter-receptor for lymphocyte function-associated antigen 1. J Exp Med 1993: 177: 1187-1192.
10. 2, binds preferentially to ICAM-3. Immunity 1995: 3: 683-690.
11. Juan M, Vilella R, Milà J et al. CDw50 and ICAM-3: two names for the same molecule. Eur J Immunol 1993: 23: 1508-1512.
12. Vilella R, Milà J, Lozano F, Alberola-Ila J, Places L, Vives J. Involvement of the CD50 molecule in allorecognition. Tissue Antigens 1990: 36: 203-210.
13. lck in Jurkat T-cell line. J Exp Med 1994: 179: 1747-1758.
14. Cid MC, Esparza J, Juan M et al. Signalling through CD50 (ICAM-3) stimulates T Lymphocyte binding to human umbilical vein endothelial cells and extracellular matrix proteins via an increase in B1 and B2 integrin function. Eur J Immunol 1995: 24: 1377-1383.
15. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon, tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986: 137: 245-254.
16. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987: 51: 813-819.
17. Nortamo P, Salcedo R, Timonen T, Prieto J, Patarroyo M, Gahmberg CG. the expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur J Immunol 1991: 21: 26-29.
18. Acevedo A, del Pozo MA, Arroyo AG, Sánchez-Mateos P, González-Amaro R, Sánchez-Madrid F. Distribution of ICAM-3-bearing cells in normal human tissues. Am J Pathol 1993: 143: 774-783.
19. Cordell JL, Pulford K, Turley H et al. Cellular distribution of human leukocyte adhesion molecule ICAM-3. J Clin Pathol 1994: 47: 143-147.
20. Doussis IA, Kaklamanis L, Cordell J et al. ICAM-3 expression on endothelium in lymphoid malignancy. Am J Pathol 1993: 143: 1040-1043.
21. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982: 49: 2112-2135.
22. Lennert K, Feller AC. Histopathology of non-Hodgkin's lymphomas (based on the updated Kiel classification). Berlin: Springer-Verlag, 1992.
23. Hadam MR. N11 Cluster report: CD50. In: Knapp B, Dörken B, Gilks WR et al., ed. Leukocyte typing IV. Oxford: Oxford University Press, 1989: 667-672.
24. Klickstein LB, de Fougeroles AR, York MR, Springer TA. Localization of the LFA-1 binding site on ICAM-3 (CD50) by epitope mapping and deletion mutagenesis. Tissue Antigens 1993: 42: 270 (abstr).
25. Cordell JL, Falini B, Erber W et al. Immunoenzymatic labelling of monoclonal antibodies using immune complex of alkaline phosphatase antibodies and monoclonal anti-alkaline phosphatase (APAAP). J Histochem Cytochem 1984: 32: 219-229.
26. Utz GL, Swerdlow SM. Distinction of follicular hyperplasia from follicular lymphoma in B-S fixed tissues. Comparison of MT-2 and bcl-2 antibodies. Hum Pathol 1993: 24: 1155-1158.
27. Thornhill MH, Wellicome SM, Mahlovz DL, Lanchbury JSS, Kyan-aung V, Haskard DO. Tumor necrosis factor combines with IL-4 or interferon gamma to selectively enhance endothelial cell adhesiveness for T-cells. The contribution of vascular cell adhesion molecule-1-dependent and independent mechanisms. J Immunol 1991: 46: 592-598.
28. Renkonen R, Paavonen T, Nortamo P, Gahmberg CG. Expresion of endothelial adhesion molecules in vivo. Increased endothelial ICAM-2 expression in lymphoid malignancies. Am J Pathol 1992: 140: 763-767.
29. Bennicelli JL, Elias J, Kern J, Guerry IV D. Production of interleukin 1 activity by cultured human melanoma cells. Cancer Res 1989: 49: 930-935.
30. Watson JM, Sensitaffar JL, Berek JS, Martinez-Maza J. Constitutive production of interleukin 6 by ovarian cells lines and primary ovarian tumor cell cultures. Cancer Res 1990: 50: 6959-6965.
31. Ruco LP, Pomponi D, Pigott R et al. Cytokine production (IL-1α, IL-1β and TNFα) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease and in non-Hodgkin's lymphomas. An immunocytochemical study. Am J Pathol 1990: 137: 1163-1171.
32. Samoszuk M, Nansen L. Detection of interleukin-5 messenger RNA in Reed Sternberg cells of Kodgkin's disease with eosinophilia. Blood 1990. 75: 13-16.
33. Hsu PI-L, Hsu S-M. Production of tumor necrosis factor a and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H″. Am J Pathol 1989: 135: 735-745.
34. Ruco LP, Pittiglio M, Dejana E, Baroni C. Vascular activation in the histopathogenesis of Hodgkin's disease: potential role of endothelial tissue factor in intravascular thrombosis and necrosis. J Pathol 1993: 171: 131-136.
35. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994: 76: 301-314.
36. Patey N, Vazeux R, Canioni D, Potter T, Gallatin WM, Brousse N. Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responses. Am J Pathol 1996: 148: 465-472.